A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

NCT04116541 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

455

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: HDM201
DRUG: Ribociclib
DRUG: Cabozantinib
DRUG: Alectinib
DRUG: Regorafenib
DRUG: Trametinib
DRUG: Dabrafenib
DRUG: Avapritinib

Sponsor

Centre Leon Berard